Volume 25, Number 3—March 2019
Research
Simplified Model to Survey Tuberculosis Transmission in Countries Without Systematic Molecular Epidemiology Programs
Table
Characteristic | Result* |
---|---|
Province | |
Panama, n = 80 | 80 (85) |
Colon, n = 14 |
14 (15) |
Antimicrobial drug susceptibility | |
Susceptible | 84 (89.4) |
Monoresistant | 6 (6.4) |
Isoniazid | 2 (2.1) |
Rifampin | 4 (4.3) |
Multidrug-resistant | 1 (1.1) |
No data |
3 (3.2) |
Lineage/sublineage | |
Lineage 1 | 3 |
East African Indian | 3 |
Lineage 2 | 7 |
Beijing | 7 |
Lineage 4 | 82 |
Latin American–Mediterranean | 31 |
Haarlem | 28 |
H37Rv-like | 18 |
Cameroon | 3 |
X | 2 |
Lineage 5 | 1 |
West_African_1 | 1 |
Lineage 6 | 1 |
West_African_2 | 1 |
Distribution of clustered isolates | |
Cluster A (Beijing) | 7 (15) |
Cluster B (Haarlem)† | 14 (30) |
Cluster C, Latin American–Mediterranean† | 9 (19) |
Cluster D (H37Rv-like) | 12 (26) |
Cluster E, Latin American–Mediterranean† | 3 (6) |
Cluster F (H37Rv-like) | 2 (4) |
*Values are no. (%) isolates or % isolates.
†One strain of this cluster was monoresistant to rifampin.
1These authors contributed equally to this article.
2These authors contributed equally to this article.
Page created: February 19, 2019
Page updated: February 19, 2019
Page reviewed: February 19, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.